Cited by — The Promising Link Among Tumor Mutational Burden, Immune-Related Adverse Events, and Immune Checkpoint Inhibitors Efficacy in SCLC | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite The Promising Link Among Tumor Mutational Burden, Immune-Related Adverse Events, and Immune Checkpoint Inhibitors Efficacy in SCLC.
No admitted local citation edges point to this work yet.
